Elizabeth Garner

With over a decade of pharmaceutical development experience, Dr. Garner brings expansive knowledge in regulatory and clinical affairs, and a deep commitment to increasing access to medicines for women globally. As a trained OB/GYN, Dr. Garner currently serves as Chief Medical Officer at ObsEva, where she focuses on addressing serious unmet needs in women’s health by providing strategic leadership on the company’s overall development strategy. Prior to joining ObsEva, Dr. Garner served as the Chief Medical Officer at Agile Therapeutics, where she successfully led the company’s clinical development, regulatory, and medical affairs strategies. During her time there, she was instrumental in obtaining the Food and Drug Administration (FDA) approval of Twirla®️, Agile’s low-dose contraceptive patch.

Dr. Garner’s past clinical roles included leading the global Phase 3 endometriosis clinical development program for Orilissa®️ at Abbott Laboratories and working on FDA submissions for the HPV vaccine, Gardasil®️. Her commitment to advocating for progress in women’s health has driven her to volunteer on several nonprofit boards including the American Medical Women’s Association (AMWA) the Drug Information Association (DIA), and CorStone, a global nonprofit focused on resilience training for marginalized youth.

Dr. Garner holds a medical degree from Harvard Medical School and a master’s degree in public health from Harvard’s T.H. Chan School of Public Health with a bachelor’s degree from Mount Holyoke College in Massachusetts.